ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2213

RA-Associated Autoantibodies Promote Synovial Fibroblasts Migration and Adhesion through a Peptidylarginine Deiminases (PAD) Dependent Pathway

Meng Sun1, Vijay Joshua2, Aase Haj Hensvold1,3, Khaled Amara4, Vivianne Malmström1, Heidi Wähämaa1 and Anca I Catrina1, 1Rheumatology Unit, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, 2Unit of Rheumatology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 3Rheumatology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden, Stockholm, Sweden, 4Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: anti-CCP antibodies, fibroblasts and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Biology and Pathology of Bone and Joint: Bone Remodeling and Metabolism

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

The presence of anti-citrullinated proteins antibodies (ACPAs) in RA is associated with a more aggressive disease phenotype and bone destruction. Synovial fibroblasts (SFs) are key players of both synovial inflammation and bone destruction in rheumatoid arthritis (RA). We aimed to invesigate the effect of ACPAs on synovial fibroblasts.

 Methods:

SFs were isolated from synovial tissue of RA patients (RA SFs) by enzymatic digestion. ACPA positive and negative IgGs were separated from plasma of RA patients and monoclonal ACPAs were generated from synovial fluid single B-cells. The effect of polyclonal and monoclonal ACPAs and appropriate negative controls was tested in migration scratch assays and adhesion assays by xCELLigence System Real-Time Cell Analyzer (ACEA bioscience). Light microscopy images were analyzed using NIH ImageJ to calculate migration index. Impedance-based signals were monitored every minute for1 hour, every 5 minutes up to 13 hours and every 15 minutes up to 36 hours. Inhibition of phosphoinositide 3-kinase (PI3K), G-protein coupled receptors, focal adhesion kinase (FAK) and peptidylarginine deiminases (PAD) inhibitor were tested in migration scratch assays in the presence or absence of the antibodies. 

Results:

Polyclonal ACPAs but not others IgGs than ACPAs induced a 2.6±0.5 (mean±SD) fold increase in RASFs migration (p<0.05). ACPAs also induced a significant fold increase in RASFs adhesion of 1.3±0.1 (p<0.05). Similar effects were observed with one (D10), but not others two monoclonal ACPAs, with a fold increase of 2.4±0.4 (p<0.05) in migration index and 1.2±0.1 (p<0.05) in adhesion index.

G-protein coupled receptor blockade completely abolished ACPAs effects on RA SFs migration, while PI3K blockade decreased migration to a residual fold increase of 1.4±0.4 (mean±SD) and FAK blockade had no effect. Irreversible PAD blockade and pre-incubation of antibodies with citrulinated fibrinogen abolished ACPAs effects. No difference in either cytotoxicity or proliferation rate were observed between different treatments. 

Conclusion:

ACPAs directly mediate fibroblast migration and adhesion through a novel G protein coupled receptor and PAD-dependent mechanism. Our findings provide novel insights into the link between adaptive immunity and synovial fibroblasts.


Disclosure: M. Sun, None; V. Joshua, None; A. H. Hensvold, None; K. Amara, None; V. Malmström, None; H. Wähämaa, None; A. I. Catrina, None.

To cite this abstract in AMA style:

Sun M, Joshua V, Hensvold AH, Amara K, Malmström V, Wähämaa H, Catrina AI. RA-Associated Autoantibodies Promote Synovial Fibroblasts Migration and Adhesion through a Peptidylarginine Deiminases (PAD) Dependent Pathway [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/ra-associated-autoantibodies-promote-synovial-fibroblasts-migration-and-adhesion-through-a-peptidylarginine-deiminases-pad-dependent-pathway/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ra-associated-autoantibodies-promote-synovial-fibroblasts-migration-and-adhesion-through-a-peptidylarginine-deiminases-pad-dependent-pathway/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology